Among these, UNC5B-AS1 was found to be a risk factor for poor osteosarcoma prognosis (Yang et al., 2022), promoting liver cancer cell migration, growth, and epithelial-mesenchymal transition (Huang et al., 2021), as well as exhibiting high expression levels in papillary thyroid carcinoma (Kim et al., 2022). This evidence concerns the gene UNC5B and liver cancer.